IDH2 and myelodysplastic syndrome: Point mutations in the active site of IDH2 affecting Arg140 or Arg172 (R140 or R172) result in multiple tumours including; low-grade gliomas, secondary glioblastomas (GBM), angioimmunoblastic T-cell lymphomas, myelodysplastic syndrome (MDS), and AML.11–13